CAR T Cell Therapy
Cardio-oncological evaluation* AND Troponin, NT-proBNP
before cancer treatment begins
ECG AND Troponin AND NT-proBNP
at Day 7 after CAR T Cell infusion AND
if cardiovascular symptoms/signs AND
if cytokine release syndrome occurs
* A cardio-oncological evaluation will systematically include at least one visit with blood pressure, blood glucose, lipid profile, GFR calculation, ECG and trans-thoracic echocardiography (TTE). Measurements of global longitudinal strain and 3D LVEF (if feasible) are recommended with the same machine.